. Author manuscript; available in PMC: 2013 May 23.

Published in final edited form as: Cancer Lett. 2011 Jan 7;301(2):221–228. doi: 10.1016/j.canlet.2010.12.015

Table 1.

Percentage of PI-positive cells in living H22 or K562 cells treated with MG132 or MG262 in the absence or presence of gambogic acid.

Cell type	Treatment		PI(+)%	Treatment		PI(+)%
K562	MG132	GA		MG262	GA
	0.000	0.0	–	0.00000	0.0	–
	0.125	0.0	–	0.00625	0.0	–
	0.250	0.0	–	0.01250	0.0	–
	0.500	0.0	3	0.02500	0.0	3
	1.000	0.0	9	0.05000	0.0	10
	0.000	0.4	6	0.00000	0.4	5
	0.125	0.4	18	0.00625	0.4	4
	0.250	0.4	50	0.01250	0.4	15
	0.500	0.4	70	0.02500	0.4	40
	1.000	0.4	85	0.05000	0.4	65
H22	0.000	0.0	–	0.00000	0.0	–
	0.000	0.4	3	0.00000	0.4	4
	1.000	0.0	5	0.02500	0.0	6
	1.000	0.4	35	0.02500	0.4	30

Percentage of PI-positive cells represents the average of three fields, “–” represents less than 3% PI-positive cells.